查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1945831

免疫力增強產品市場－全球產業規模、佔有率、趨勢、機會及預測（按類型、通路、地區及競爭格局分類，2021-2031年）

Immunity Boosting Products Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Distribution Channel, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球免疫增強產品市場預計將從 2025 年的 311.6 億美元成長到 2031 年的 481.4 億美元，複合年成長率為 7.52%。

這些產品包括膳食補充劑、機能性食品和飲料，其中添加了維生素、礦物質、益生菌和植物萃取物等活性成分，旨在增強人體免疫系統。市場成長的關鍵促進因素是消費行為向健康保健方向的結構性轉變，人們越來越重視長期健康維護和疾病預防，而非被動治療。全球人口老化和人們對營養缺乏的日益關注進一步支撐了這種持續的需求，確保該品類全年保持旺盛的市場地位。例如，根據責任營養委員會 (CRN) 2024 年發布的報告，30% 的膳食補充劑消費者表示，增強免疫力是他們服用這些產品的主要動機，這凸顯了該行業的持續活力。

市場概覽
預測期 2027-2031
市場規模：2025年 311.6億美元
市場規模：2031年 481.4億美元
複合年成長率：2026-2031年 7.52%
成長最快的細分市場 補充
最大的市場 北美洲

儘管全球免疫增強產品市場呈現積極的成長趨勢，但由於各國監管法規的零碎化，該市場仍面臨許多挑戰。在健康聲明、成分安全標準和標籤要求等方面，標準的不一致給尋求全球擴張的製造商設置了重重障礙。這種監管上的不一致往往迫使企業針對特定市場定製配方，從而增加生產成本，降低供應鏈效率，阻礙市場快速擴張。

市場促進因素

全球免疫增強產品市場的主要驅動力是消費者對醫療保健和健康維護日益成長的興趣。這從根本上改變了人們的購買習慣，從季節性應對轉向日常主動管理。人們越來越意識到持續免疫力與長壽之間的聯繫，促使他們將免疫支持產品融入日常生活。近期消費者意識調查也印證了這個趨勢。協和發酵工業株式會社於2024年9月發布的《2024年及以後的免疫健康》報告顯示，51%的消費者比兩年前更加關注自體免疫健康。這種日益成長的關注和重視程度的提高，推動了對能夠提供持續保護而非暫時緩解的膳食補充劑和功能性產品的穩定需求。

此外，市場成長也受到消費者對天然、有機和植物來源成分需求激增的推動。消費者越來越注重標籤上經過科學檢驗的純淨成分，這為關鍵免疫調節成分的供應鏈帶來了顯著的偏好。根據全球EPA和DHA Omega-3 3組織於2024年9月發布的《2024年全球EPA和DHA Omega-3-3成分市場報告》，全球Omega-3成分市場預計在2023年將成長22.5%，這反映了成本上升和優質化趨勢。此外，國際益生菌協會（IPA）預測，亞太地區益生菌補充劑的銷售額將在2024年至2028年期間維持9.2%的年成長率，這印證了該地區對天然免疫解決方案的強勁需求。

市場挑戰

國際監管體系的分散化仍是限制全球免疫增強產品市場成長的一大障礙。製造商面臨不同的健康聲明和成分安全標準，這阻礙了他們有效利用規模經濟。這種情況迫使企業開發相同產品的多種變體以符合相互衝突的當地法律，這不可避免地增加了生產成本並使供應鏈物流更加複雜。因此，與合規、重新貼標和配方調整相關的巨額成本佔用了原本可以投入研發和市場開發的資金。

這種碎片化的監管環境阻礙了企業進入新市場的能力，並造成了營運摩擦。當分散化發生在單一主要市場內部時，這種複雜性會進一步加劇，為本已複雜的市場環境增添新的難度。例如，根據天然產品協會 (NPA) 2024 年的報告，已有 13 個州表示有意考慮建立州級法規結構，這有可能用一系列地方性法規取代統一的聯邦框架。這種監管的不確定性迫使企業採取謹慎的分階段擴張策略，而不是實施激進的全球策略。

市場趨勢

隨著消費者越來越意識到心理健康與免疫力之間的心理生物學聯繫，免疫功能與壓力和睡眠支持的融合正在迅速發展。消費者不再孤立地關注單一健康要素，而是越來越傾向於透過整體療法來最佳化他們的健康習慣，從而同時管理焦慮、睡眠不足和增強免疫力。這種對多功能解決方案的需求得到了數據的支持，這些數據顯示了人們健康優先事項的轉變。根據報導-Firmenich於2024年12月發布的《健康生活：最新全球消費者洞察》報告，心理和情緒健康（48%）以及免疫力（44%）同時被列為最重要的健康問題，這推動了結合免疫調節劑、適應原和放鬆成分的混合產品的開發。

同時，市場正積極推動將免疫益處融入機能性食品和飲料，使該品類擺脫傳統的藥品形式。為了應對“服藥疲勞”，生產商正在零食、優格和果汁等日常消費品中添加增強免疫力的成分，使健康管理成為日常營養的自然組成部分，而非一項醫療任務。這種朝向生活方式導向產品的拓展，主要受消費者需求的驅動。根據協和發酵工業株式會社於2024年9月發布的《2024年後的免疫健康》報告，74%的膳食補充劑消費者表示會考慮食用有助於增強免疫力的食品和飲料，這充分證明了向強化功能性營養的戰略轉變是合理的。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球免疫力增強產品市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 按類型（補充劑、飲料、食品、其他）
    • 按分銷管道（超級市場/大賣場、便利商店、藥局、線上）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章 北美免疫力產品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲免疫力產品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章 亞太地區免疫力增強產品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章 中東和非洲免疫力增強產品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章 南美洲免疫力提升產品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球免疫力增強產品市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Amway Corporation
  • Herbalife Nutrition Ltd.
  • Nestle SA
  • Pfizer Inc.
  • Bayer AG
  • NOW Foods
  • Nature's Bounty Co.
  • GNC Holdings, Inc.
  • Himalaya Drug Company
  • Glanbia plc

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 5038

The Global Immunity Boosting Products Market is projected to expand from USD 31.16 Billion in 2025 to USD 48.14 Billion by 2031, progressing at a CAGR of 7.52%. These products encompass dietary supplements, functional foods, and beverages fortified with active ingredients like vitamins, minerals, probiotics, and botanicals designed to strengthen the human immune system. Market growth is primarily driven by a structural transition in consumer behavior toward preventive healthcare, where individuals prioritize long-term wellness and disease avoidance over reactive medical treatments. This sustained demand is further supported by an aging global population and increased awareness of nutritional deficiencies, ensuring the category remains relevant throughout the year. For instance, the Council for Responsible Nutrition reported in 2024 that 30 percent of dietary supplement users identified immune health as a leading motivation for their regimen, highlighting the sector's enduring vitality.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 31.16 Billion
Market Size 2031USD 48.14 Billion
CAGR 2026-20317.52%
Fastest Growing SegmentSupplement
Largest MarketNorth America

Despite these positive growth trajectories, the Global Immunity Boosting Products Market encounters a substantial challenge due to regulatory fragmentation across various international jurisdictions. Inconsistent standards regarding permissible health claims, ingredient safety thresholds, and labeling requirements establish complex barriers for manufacturers seeking to scale operations globally. This regulatory disparity frequently compels companies to customize formulations for specific markets, leading to escalated production costs and supply chain inefficiencies that can hinder rapid market expansion.

Market Driver

A primary catalyst for the Global Immunity Boosting Products Market is the increasing consumer emphasis on preventive healthcare and wellness, which is fundamentally shifting purchasing habits from seasonal reactivity to proactive daily management. As individuals become more aware of the connection between immune resilience and overall longevity, they are incorporating immunity-supporting products into their everyday routines. This trend is substantiated by recent consumer sentiment; according to the 'Immune Health in 2024 and Beyond' report by Kyowa Hakko in September 2024, 51 percent of consumers expressed greater concern about their immune health compared to two years prior. This elevated anxiety and prioritization drive consistent demand for supplements and functional products that provide continuous defense rather than temporary relief.

Furthermore, the market is propelled by surging demand for natural, organic, and plant-based ingredients, as consumers increasingly examine labels for clean, scientifically validated components. This preference is generating significant economic activity within the supply chain for key immune-modulating raw materials. As noted in the '2024 Global EPA and DHA Omega-3 Ingredient Market Report' by the Global Organization for EPA and DHA Omega-3s in September 2024, the value of the global omega-3 ingredient market rose by 22.5 percent in 2023, reflecting rising costs and premiumization. Additionally, the International Probiotics Association projected in 2024 that probiotic supplement sales in the Asia Pacific region would maintain a 9.2 percent growth rate through 2028, underscoring strong regional momentum for natural immune solutions.

Market Challenge

Regulatory fragmentation across international jurisdictions remains a significant barrier restricting the growth of the Global Immunity Boosting Products Market. Manufacturers facing divergent standards regarding permissible health claims and ingredient safety limits are unable to effectively leverage economies of scale. This situation forces companies to develop multiple variations of the same product to comply with conflicting local laws, inevitably increasing production costs and complicating supply chain logistics. Consequently, financial resources that could be invested in research and market development are instead consumed by the substantial costs associated with compliance, relabeling, and reformulation.

The impact of this disjointed regulatory environment hampers the speed at which companies can enter new territories and creates operational friction. This complexity is intensified when fragmentation occurs even within single key markets, adding further layers of difficulty to an already intricate landscape. For example, the Natural Products Association reported in 2024 that 13 states demonstrated a willingness to consider creating state-level regulatory schemes, threatening to replace unified federal frameworks with a patchwork of local mandates. Such regulatory volatility compels businesses to adopt a cautious, piecemeal approach to expansion rather than executing aggressive global strategies.

Market Trends

The convergence of immunity with stress and sleep support is rapidly advancing as consumers increasingly acknowledge the psychobiological connection between mental well-being and immune resilience. Rather than addressing these health aspects in isolation, individuals are seeking holistic formulations that simultaneously manage anxiety, sleep deprivation, and immune defense, thereby optimizing their wellness regimens. This demand for multi-functional solutions is supported by data on shifting health priorities; according to the 'Health expectancy: Latest global consumer insights' article by DSM-Firmenich in December 2024, mental and emotional health (48 percent) and immunity (44 percent) were identified as top concurrent health concerns, driving the development of hybrid products combining immune-modulators with adaptogens and relaxants.

Simultaneously, the market is seeing a decisive integration of immune benefits into functional foods and beverages, shifting the category away from traditional pharmaceutical-like formats. Manufacturers are addressing "pill fatigue" by fortifying everyday consumables-such as snacks, yogurts, and juices-with immune-supporting ingredients, making health management a seamless part of daily nutrition rather than a medical task. This expansion into lifestyle-oriented formats is strongly supported by consumer interest; according to the 'Immune Health in 2024 and Beyond' report by Kyowa Hakko in September 2024, 74 percent of supplement consumers indicated they would consider foods and beverages to support their immune health, validating the strategic pivot toward fortified functional nutrition.

Key Market Players

  • Amway Corporation
  • Herbalife Nutrition Ltd.
  • Nestle S.A.
  • Pfizer Inc.
  • Bayer AG
  • NOW Foods
  • Nature's Bounty Co.
  • GNC Holdings, Inc.
  • Himalaya Drug Company
  • Glanbia plc

Report Scope

In this report, the Global Immunity Boosting Products Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Immunity Boosting Products Market, By Type

  • Supplement
  • Beverages
  • Food
  • Others

Immunity Boosting Products Market, By Distribution Channel

  • Supermarket/Hypermarkets
  • Convenience Stores
  • Medical Stores
  • Online

Immunity Boosting Products Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Immunity Boosting Products Market.

Available Customizations:

Global Immunity Boosting Products Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Immunity Boosting Products Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type (Supplement, Beverages, Food, Others)
    • 5.2.2. By Distribution Channel (Supermarket/Hypermarkets, Convenience Stores, Medical Stores, Online)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Immunity Boosting Products Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type
    • 6.2.2. By Distribution Channel
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Immunity Boosting Products Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type
        • 6.3.1.2.2. By Distribution Channel
    • 6.3.2. Canada Immunity Boosting Products Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type
        • 6.3.2.2.2. By Distribution Channel
    • 6.3.3. Mexico Immunity Boosting Products Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type
        • 6.3.3.2.2. By Distribution Channel

7. Europe Immunity Boosting Products Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type
    • 7.2.2. By Distribution Channel
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Immunity Boosting Products Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type
        • 7.3.1.2.2. By Distribution Channel
    • 7.3.2. France Immunity Boosting Products Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type
        • 7.3.2.2.2. By Distribution Channel
    • 7.3.3. United Kingdom Immunity Boosting Products Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type
        • 7.3.3.2.2. By Distribution Channel
    • 7.3.4. Italy Immunity Boosting Products Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type
        • 7.3.4.2.2. By Distribution Channel
    • 7.3.5. Spain Immunity Boosting Products Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type
        • 7.3.5.2.2. By Distribution Channel

8. Asia Pacific Immunity Boosting Products Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type
    • 8.2.2. By Distribution Channel
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Immunity Boosting Products Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type
        • 8.3.1.2.2. By Distribution Channel
    • 8.3.2. India Immunity Boosting Products Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type
        • 8.3.2.2.2. By Distribution Channel
    • 8.3.3. Japan Immunity Boosting Products Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type
        • 8.3.3.2.2. By Distribution Channel
    • 8.3.4. South Korea Immunity Boosting Products Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type
        • 8.3.4.2.2. By Distribution Channel
    • 8.3.5. Australia Immunity Boosting Products Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type
        • 8.3.5.2.2. By Distribution Channel

9. Middle East & Africa Immunity Boosting Products Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type
    • 9.2.2. By Distribution Channel
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Immunity Boosting Products Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type
        • 9.3.1.2.2. By Distribution Channel
    • 9.3.2. UAE Immunity Boosting Products Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type
        • 9.3.2.2.2. By Distribution Channel
    • 9.3.3. South Africa Immunity Boosting Products Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type
        • 9.3.3.2.2. By Distribution Channel

10. South America Immunity Boosting Products Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type
    • 10.2.2. By Distribution Channel
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Immunity Boosting Products Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type
        • 10.3.1.2.2. By Distribution Channel
    • 10.3.2. Colombia Immunity Boosting Products Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type
        • 10.3.2.2.2. By Distribution Channel
    • 10.3.3. Argentina Immunity Boosting Products Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type
        • 10.3.3.2.2. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Immunity Boosting Products Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Amway Corporation
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Herbalife Nutrition Ltd.
  • 15.3. Nestle S.A.
  • 15.4. Pfizer Inc.
  • 15.5. Bayer AG
  • 15.6. NOW Foods
  • 15.7. Nature's Bounty Co.
  • 15.8. GNC Holdings, Inc.
  • 15.9. Himalaya Drug Company
  • 15.10. Glanbia plc

16. Strategic Recommendations

17. About Us & Disclaimer